J
Jiun-Ruey Hu
Researcher at Vanderbilt University Medical Center
Publications - 57
Citations - 773
Jiun-Ruey Hu is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 31 publications receiving 416 citations. Previous affiliations of Jiun-Ruey Hu include Central South University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Cardiovascular toxicities associated with immune checkpoint inhibitors.
Jiun-Ruey Hu,Roberta Florido,Evan J. Lipson,Jarushka Naidoo,Reza Ardehali,Carlo G. Tocchetti,Alexander R. Lyon,Robert F. Padera,Douglas B. Johnson,Javid Moslehi +9 more
TL;DR: A narrative review describes the epidemiology, diagnosis, pathophysiology, and treatment of cardiovascular toxicities of ICI therapy, highlighting recent developments in the field in the past year.
Journal ArticleDOI
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses
Jiun-Ruey Hu,Meredith S. Duncan,Alicia K. Morgans,Jonathan D. Brown,Wouter C. Meijers,Matthew S. Freiberg,Matthew S. Freiberg,Joe-Elie Salem,Joe-Elie Salem,Joshua A. Beckman,Javid Moslehi +10 more
TL;DR: A divergence is found between observational studies, which show consistent positive associations between androgen deprivation therapy use and cardiovascular disease, and randomized controlled trials, which do not show these associations reproducibly.
Journal ArticleDOI
Cellular Mechanisms of Alpha Herpesvirus Egress: Live Cell Fluorescence Microscopy of Pseudorabies Virus Exocytosis
TL;DR: This work proposes an integrated model that links together the intracellular transport pathways and exocytosis mechanisms that mediate alpha herpesvirus egress, and describes how individual virus particles travel to the plasma membrane inside small, acidified secretory vesicles.
Journal ArticleDOI
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis.
Stephen P. Juraschek,Jiun-Ruey Hu,Jennifer L Cluett,Anthony Ishak,Carol Mita,Lewis A. Lipsitz,Lawrence J. Appel,N Beckett,Ruth L. Coleman,William C. Cushman,Barry R. Davis,Greg Grandits,Rury R. Holman,Edgar R. Miller,Ruth Peters,Jan A. Staessen,Addison A. Taylor,Lutgarde Thijs,Jackson T. Wright,Kenneth J. Mukamal +19 more
TL;DR: Intensive BP-lowering treatment decreases risk for OH, and orthostatic hypotension, before or in the setting of more intensive BP treatment, should not be viewed as a reason to avoid or de-escalate treatment for hypertension.
Journal ArticleDOI
Serum metabolites are associated with all-cause mortality in chronic kidney disease.
Jiun-Ruey Hu,Josef Coresh,Lesley A. Inker,Andrew S. Levey,Zihe Zheng,Casey M. Rebholz,Adrienne Tin,Lawrence J. Appel,Jingsha Chen,Mark J. Sarnak,Morgan E. Grams +10 more
TL;DR: In this paper, the authors determined which serum metabolites reproducibly associate with mortality in chronic kidney disease (CKD) using a discovery and replication design, and replicated associations with mortality from the African American Study of Kidney Disease and Hypertension (AASK) cohort over a median follow-up of ten years.